Learning Objectives:
At the conclusion of this educational program, learners will be able to:

1. Describe pain mechanisms and pain syndromes and how they can inform appropriate treatment options.
2. Describe nonpharmacologic and pharmacologic therapies that can be incorporated in a comprehensive pain management plan.
3. Discuss characteristics of opioids and their role in pediatric pain management.
4. Describe best practices for prescribing, administration, and storage of opioids to ensure safe and effective pain management.
5. Identify evidence-based tools for the recognition, evaluation, and management of pediatric pain.

Accreditation

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician

Boston Children’s Hospital designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity. AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.

RISK MANAGEMENT

This activity meets the requirements for 3.00 Risk Management Credits as proscribed by the Massachusetts Board of Registration in Medicine and defined in 243 CMR 2.06(5)(d) I. Please check your individual state licensing board requirements before claiming these credits.
MOC PART II

AMERICAN BOARD OF PEDIATRICS

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 3.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

AMERICAN BOARD OF INTERNAL MEDICINE

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

AMERICAN BOARD OF ANESTHESIOLOGY

Successful completion of this CME activity, which includes participation in the activity, with individual assessment of the participant and feedback to the participant, enables the participant to earn 3.00 MOC points with the American Board of Anesthesiology Maintenance of Certification in Anesthesiology Program® (MOCA®). It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Nurse

Boston Children’s Hospital designates this activity for 3.00 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistant

Boston Children’s Hospital has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Pharmacy

This activity carries a maximum of 3.00 contact hours. Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Course Directors

David Casavant, MD
Senior Associate in Critical Care Medicine
Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital
Assistant Professor of Anesthesia, Harvard Medical School

Kathleen Huth, MD, MMSc, FRCPC
Pediatrician & Director of Ambulatory Quality Improvement, Complex Care Service
Program Director, Complex Care Fellowship, Boston Children’s Hospital
Assistant Professor of Pediatrics, Harvard Medical School

Traci Wolbrink, MD, MPH
Co-Director, OPENPediatrics; Senior Associate in Critical Care Medicine
Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital
Associate Professor of Anesthesia, Harvard Medical School

Authors

David Casavant, MD
Senior Associate in Critical Care Medicine
Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital
Assistant Professor of Anesthesia, Harvard Medical School

Charles Berde, MD, PhD
Senior Associate in Perioperative Anesthesia and Pain Medicine
Department of Anesthesia, Critical Care and Pain Medicine, Boston Children’s Hospital
Professor of Anesthesia (Pediatrics), Harvard Medical School

Sharon Levy, MD, MPH
Director, Adolescent Substance Abuse Program (ASAP), Boston Children’s Hospital
Associated Professor in Pediatrics, Harvard Medical School

Jean Solodiuk, RN, PhD
Pediatric Nurse Practitioner/Nurse Manager/Nurse Scientist
Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital
Instructor of Anesthesia, Harvard Medical School

Clifford Woolf, MB, BCh, PhD
Director, F.M. Kirby Neurobiology Center Center, Boston Children’s Hospital
Professor of Neurology and Neurobiology, Harvard Medical School

Disclosures

Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients:
Clifford Woolf, MB, BCh, PhD: Nocion Therapeutics – Founder
Charles Berde, MD, BCh, PhD: Latigo Biotherapeutics – Research Support; Akelos, Inc. – Scientific Advisory Board
David Casavant, MD: None
Charles Berde, MD, PhD: None
Sharon Levy, MD, MPH: None
Traci Wolbrink, MD, MPH: None
Jean Soloduik, RN, PhD: None
Bianca Quiñones-Pérez, MD: None